Loading...
StocksRunner logo
 
 
Amarin plc
1.29
+1.98%
 
AMRN Amarin plc
Last Price
Change
1.29
 
+1.98%
 
 
 

 
Sentiment
 
  Login to display
 
 

1.27

1.52

1.86

1.92

 
 
1m
3m
6m
1y
 

Summary

Amarin plc (AMRN) still has no score becuse there is not enough information which allows us to analyze the activity of the stock over a period of time
 
 

Risk Level

 
StocksRunner
 

Amarin plc (AMRN) has Low Risk Level

Click here to check what is your level of risk

 

Analysts Opinion

Click on the category for more information
 
 

Earnings

×
 

Earnings

2.67
 

StocksRunner

 Sales decline

 
 

Rating

×
 

Rating

NA
 
 

Momentum

×
 

Momentum

4.00
 

StocksRunner

 Has been gaining momentum

 

Activity

×
 

Activity

3.67
 
 

Future

×
 

Future

1.00
 
 
 

Analysts Opinion

Analysts opinion is negative and it remained unchanged from the past 3 months

 

Street Consensus

Buy
Opinion
Trend
Score
Potential
Score
 
57%
NA
100%
0%
 
On Track
On Track
On Track
 

Street Opinion 

Street view is bullish and have negative views on the near-term outlook

 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
Positive vs Negative
 
57%
29%
Positive
Negative
4 out of 7
events present
2 out of 7
events present
 

 
Events Calendar
Click for more information
 
May
S
M
T
W
T
F
S
June
S
M
T
W
T
F
S
 
Highlights
Last
Modify
Closing
Price
%
Change

 
Investors Activity
1 Day Ago
1.29
+1.98%
 
Investors Activity
This Week
1.21
+3.42%
 
Weak Earnings
2 Month Ago
1.36
-3.55%
 
Top Headlines

amarin corporation plc (amrn) presents at jefferies 2023 global healthcare conference (transcript).

Wed Jun 7, 2023

Activity

amarin to present at two upcoming investor conferences. ) today announced that aaron berg amarin'.s interim president and chief executive officer and tom reilly amarin'.s chief financial officer will present at two upcoming inves

Thu Jun 1, 2023

Activity

amarin gains as heart disorder therapy vascepa cleared in china.

Thu Jun 1, 2023

Momentum

amarins (amrn) q1 earnings top vascepa sales fall. amarin corporation plcamrn reported first-quarter 2023 adjusted earnings of 2 cents per share which beat the zacks consensus estimate and our model estimate of a loss of 1 cent per sha

Wed May 3, 2023

Earnings
Earnings

amarin non-gaap eps of -$0.02 misses by $0.01 revenue of $85.7m beats by $4.47m.

Wed May 3, 2023

Earnings

amarin names aaron berg as interim president & ceo.

Mon Apr 17, 2023

Activity

 
 
 
StocksRunner

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our daily AMRN alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

 
Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

 
Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
About Us

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
StocksRunner

StocksRunner

Get the pulse of the market

 
StocksRunner

AMRN Amarin plc

Last Price
1.29
Change
+1.98%
 

Summary

Amarin plc (AMRN) still has no score becuse there is not enough information which allows us to analyze the activity of the stock over a period of time

 
 
1.27
1.52
1.86
1.92
 
 
1m
3m
6m
1y
 
Sentiment
 

  Login to display
 
 
 
 
Street Consensus
 
Buy
Opinion
Trend
Score
Potential
Score
 
NA
100%
0%
On Track
On Track
On Track
 
57%
29%
Positive
Negative
4 out of 7
events present
2 out of 7
events present
 

Street Opinion

Street view is bullish and have negative views on the near-term outlook

 
 
Analysts Opinion
Hover the category for more information
 
 

Earnings

×
 

Earnings

2.67
 

StocksRunner

 Sales decline

 
 

Rating

×
 

Rating

NA
 
 

Momentum

×
 

Momentum

4.00
 

StocksRunner

 Has been gaining momentum

 

Activity

×
 

Activity

3.67
 
 

Future

×
 

Future

1.00
 
 
 

Analysts Opinion

Analysts opinion is negative and it remained unchanged from the past 3 months

 
 
 
 
 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 
Risk Level
 
StocksRunner
 

Amarin plc (AMRN) has Low Risk Level.  Click here to check what is your level of risk

 
 
 

Events Calendar

Hover for information

 
May
 
S
M
T
W
T
F
S
 
June
 
S
M
T
W
T
F
S
 
 
 
 
Highlights
Last
Modify
Closing
Price
%
Change

 
Investors Activity
1 Day Ago
1.29
+1.98%
 
Investors Activity
This Week
1.21
+3.42%
 
Weak Earnings
2 Month Ago
1.36
-3.55%
 
 
 
StocksRunner

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our daily AMRN Alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
 
 

Top Headlines